Alyeska Investment Group
JAZZ icon

Alyeska Investment Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Alyeska Investment Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-411,015
Closed -$77.7M – 730
2026
Q1 		$77.7M Buy
411,015
+87,631
+27% +$15.3M 0.22% 129
2025
Q4 		$55M Buy
323,384
+117,430
+57% +$18M 0.16% 167
2025
Q3 		$27.1M Buy
205,954
+2,086
+1% +$250K 0.08% 251
2025
Q2 		$21.6M Buy
+203,868
New +$22.1M 0.08% 272
2025
Q1 		– Sell
-228,101
Closed -$28.1M – 586
2024
Q4 		$28.1M Buy
+228,101
New +$26.9M 0.11% 222
2021
Q1 		– Sell
-4,691
Closed -$774K – 781
2020
Q4 		$774K Sell
4,691
-123,243
-96% -$18.4M 0.01% 429
2020
Q3 		$18.2M Sell
127,934
-77,516
-38% -$9.61M 0.28% 113
2020
Q2 		$22.7M Buy
205,450
+199,452
+3,325% +$22.1M 0.34% 104
2020
Q1 		$598K Buy
+5,998
New +$776K 0.01% 322
2019
Q4 		– Sell
-5,124
Closed -$657K – 455
2019
Q3 		$657K Buy
+5,124
New +$687K 0.01% 347
2016
Q3 		– Sell
-352,399
Closed -$49.8M – 494
2016
Q2 		$49.8M Buy
352,399
+103,946
+42% +$15.3M 0.47% 73
2016
Q1 		$32.4M Buy
248,453
+237,210
+2,110% +$29.5M 0.3% 131
2015
Q4 		$1.58M Sell
11,243
-218,587
-95% -$30.3M 0.02% 315
2015
Q3 		$30.5M Buy
229,830
+77,384
+51% +$13.3M 0.36% 107
2015
Q2 		$26.8M Buy
152,446
+87,366
+134% +$15.7M 0.3% 118
2015
Q1 		$11.2M Buy
+65,080
New +$11.2M 0.16% 217

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Alyeska Investment Group's JAZZ Position: Q2 2026 in Review

Alyeska Investment Group sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2026, closing a stake of 411,015 shares — an estimated $77.7M sold.

Alyeska Investment Group first reported a position in JAZZ in Q1 2015 and held it in 16 quarters. The position peaked at $77.7M in Q1 2026. 641 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Alyeska Investment Group reported no remaining Jazz Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Alyeska Investment Group sold 411,015 Jazz Pharmaceuticals shares in Q2 2026, an estimated $77.7M.
  • Alyeska Investment Group first reported a position in Jazz Pharmaceuticals in Q1 2015 and held it in 16 quarters.
  • Alyeska Investment Group's Jazz Pharmaceuticals position peaked at $77.7M in Q1 2026.
  • 641 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Alyeska Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.